Completed Bones, Joints & Muscles Genetics & Molecular Biology

A UK resource of new models of bone and mineral disorders

In plain English

AI plain-English summary

A systematic breeding programme will create new mouse strains to uncover the genetic roots of common bone and joint diseases. Nearly everyone will develop a bone, joint, or mineral disorder—such as osteoporosis, osteoarthritis, gout, or kidney stones—at some point. Many of these conditions have a genetic component, but scientists lack the animal models needed to pinpoint the specific genes involved. This programme addresses that gap by breeding mice until they develop disease-relevant traits, then identifying the responsible genes. Because many experiments possible in mice are impossible in humans, this approach can reveal causal mechanisms that human studies alone cannot. If successful, this work will produce a publicly available UK resource of new mouse models for bone and mineral disorders. Researchers could use these models to test potential treatments, screen drugs, and understand why some people are more susceptible than others. The ultimate impact would be new therapies for conditions that currently have limited treatment options, affecting millions of people. This is fundamental science with a clear translational pathway—it does not promise immediate cures, but it builds the essential experimental toolkit needed to develop them.

View original technical description
Genetic abnormalities are important in the causation of many common human diseases of bones, joints and the minerals important in their makeup. These conditions combined affect nearly all humans. Studies of mice are important in understanding the role of genes in these diseases, as there are many experiments that can be performed with mice that are impossible in humans both ethically and for practical reasons. Currently there are many conditions for which no mouse model has been identified. This programme will systematically breed new mouse strains to identify mice developing phenotypes relevant to conditions such as osteoporosis, osteoarthritis, gout, cancer and kidney stones. Identifying the genes involved in these mice will help us to understand what causes the same conditions in humans. This knowledge will lead to the development of new treatments for these conditions in humans.

View the original record at the funder ↗

Researchers

Matthew Brown (Co-Investigator)Peter Croucher (Co-Investigator)Rajesh Thakker (Principal Investigator)Roger Cox (Co-Investigator)Stephen Brown (Co-Investigator)

Related Research

Grants with similar aims, by meaning.

Identification of Novel Drug Targets for Osteoporosis through Characterisation of the Genetic Basis of High Bone Mass
Characterisation and therapeutic intervention of two novel mouse models of Paget's disease of bone
Characterization of low bone mass phenotypes in 3 knockout mouse strains from the Wellcome Trust Sanger Institute high throughput gene targeting pipeline
A genetic approach to develop novel mouse models of liver disease
Virtual Mouse and Human Twins for optimising Treatments for Osteoporosis

Original classification

Research Grant

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.